A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Trial Identifier: D7350C00001
Sponsor: AstraZeneca
Start Date: July 2025
Primary Completion Date: October 2029
Study Completion Date: October 2029
Condition: Cancer - Other; Skin Cancer; Lung Cancer; Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU East Melbourne, AU, 3002
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 227-8577
US, MI Grand Rapids, MI, US, 49546
US, MO Saint Louis, MO, US, 63110
US, PA Pittsburgh, PA, US, 15232
US, TX Houston, TX, US, 77030
US, TX San Antonio, TX, US, 78229